Acquisition

October 01, 2026 The Manager Listing Department, The National Stock Exchange of India Limited Exchange Plaza, Bandra Kurla Complex, Bandra (E), Mumbai – 400051 Dear Sir/ Madam, Trading Symbol: ZOTA Sub: Intimation of Acquisition of 21,00,000 equity shares of M/s KMHP Ventures Limited, Wholly Owned Subsidiary of the Company, by way of subscription to the right issue. Ref.: Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 With reference to the captioned subject; we, M/s Zota Health Care Limited (the “Company”), would like to inform you that the Company has acquired 21,00,000 equity shares of M/s KMHP Ventures Limited, Wholly Owned Subsidiary (“WOS”) of the Company, by way of subscription to the right issue. The details required under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 are annexed herewith as Annexure-1. This is for your information and record. Thanking you, Yours faithfully, For Zota Health Care Limited Ashvin Variya (Group Company Secretary & Compliance Officer) Place: Surat Encl.: a/a Registered Office: Zota House, 2/896, Hira Modi Street, Sagrampura, Surat-395002 Ph: +91 261 2331601 Email: info@zotahealthcare.com Web: www.zotahealthcare.com CIN: L24231GJ2000PLC038352 Annexure-1 Particulars Details Name of the target entity, details in brief i. Name of the Target Entity: KMHP Ventures Limited such as size, turnover etc. ii. Business of the Target Entity: WOS has an object of doing business in the pharmaceutical segment and in process of rolling out retail stores under the brand name of “Ugo Generic” which will operate in both Business to Business (B2B) and Business to Consumer (B2C) model. iii. Financial details: As per the audited financial statements for the Financial Year 2025-26, the turnover of WOS was Rs. NIL. At present, the total paid-up share capital is Rs. 210.00 lakhs. Whether the acquisition would fall within No, the acquisition does not fall within the ambit of related related party transaction(s) and whether party transactions. The promoter/ promoter group/ group the promoter/ promoter group/ group companies do not have any interest in WOS and the said companies have any interest in the entity transaction is done at arm’s length basis. being acquired? If yes, nature of interest and details thereof and whether the same is done at “arm’s length” Industry to which the entity being acquired Pharmaceutical belongs Objects and effects of acquisition (including The Company has made investment in WOS as a part of but not limited to, disclosure of reasons for strategic investment; wherein WOS is in process of rolling out acquisition of target entity, if its business is retail store chain under the brand name of “Ugo Generic” outside the main line of business of the which will operate in both Business to Business (B2B) and listed entity); Business to Consumer (B2C) model and offer high quality generic medicines on a PAN India basis through its owned stores as well as ~12.5 lakhs retail pharmacies to be onboarded under Ugo Generic, expansion for stores to be opened and to mitigate working capital requirements of WOS. Post to this acquisition, M/s KMHP Ventures Limited continues to remain as the WOS of the Company. Brief details of any governmental or N.A. regulatory approvals required for the acquisition Indicative time period for completion of the On October 01, 2026, the Company has acquired the said acquisition 21,00,000 equity shares of WOS by subscription to the right issue. Nature of consideration - whether cash Cash consideration by way of acquisition of Equity Shares. consideration or share swap and details of the same; Cost of acquisition or the price at which the Cost of acquisition for subscription of 21,00,000 Equity Shares shares are acquired offered on right basis is Rs. 10.00/- per equity share aggregating to Rs. 2,10,00,000.00/-. Percentage of shareholding/ control The Company has further acquired 21,00,000 equity shares of acquired and/ or number of shares acquired WOS. Post to this acquisition, M/s KMHP Ventures Limited continues to remain as the WOS of the Company. Brief background about the entity acquired M/s KMHP Ventures Limited was incorporated on January 13, in terms of products/line of business 2026, domiciled in India; engaged in the business of acquired, date of incorporation, history of pharmaceutical segment and planning to rollout retail stores last 3 years turnover, country in which the under the brand name of “Ugo Generic” which will operate in acquired entity has presence and any other both Business to Business (B2B) and Business to Consumer significant information (in brief) (B2C) model and offer high quality generic medicines on a PAN India basis through its owned stores as well as ~12.5 lakhs retail pharmacies to be onboarded under Ugo Generic. During last three financial years, the details of turnover of WOS were as follows: FY 2025-26: Rs. NIL FY 2024-25: N.A. FY 2023-24: N.A.